Efficacy of niraparib in patients with advanced ovarian cancer: A meta-analysis of randomized controlled trials

被引:0
|
作者
Marinho, Alice
Fossen, Eduardo Lambert
Caldeira de Freitas, Maria Carolina
Itaya, Gabriela Coelho
Da Costa, Larissa Maria
Dias, Yasmin
Goncalves Celso, Davi Said
Dos Santos, Marcela Bonalumi
De Souza, Mariana
Vilbert, Maysa
机构
[1] Fed Univ State Rio De Janeiro, Rio De Janeiro, Brazil
[2] Fac Santa Marcelina, Sao Paulo, Brazil
[3] Univ Brasilia, Brasilia, DF, Brazil
[4] Univ South Santa Catarina, Tubarao, Brazil
[5] Univ Fed Acre, Rio Branco, Brazil
[6] Washington Univ St Louis, St Louis, MO USA
[7] Univ Fed Vicosa, Vicosa, MG, Brazil
[8] Oncoclin & Co Med Scientia Innovat Res MEDSIR, Sao Paulo, Brazil
[9] Univ Fed Parana, Curitiba, Parana, Brazil
[10] Massachusetts Gen Hosp Canc Ctr, Boston, MA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5587
引用
收藏
页数:1
相关论文
共 50 条
  • [1] The efficacy and toxicity of angiogenesis inhibitors for ovarian cancer: a meta-analysis of randomized controlled trials
    Chongzhen Guo
    Chengda Yan
    Lianyue Qu
    Rongrong Du
    Jianyang Lin
    [J]. Archives of Gynecology and Obstetrics, 2021, 303 : 285 - 311
  • [2] The efficacy and toxicity of angiogenesis inhibitors for ovarian cancer: a meta-analysis of randomized controlled trials
    Guo, Chongzhen
    Yan, Chengda
    Qu, Lianyue
    Du, Rongrong
    Lin, Jianyang
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2021, 303 (02) : 285 - 311
  • [3] Safety of Bevacizumab in Patients with Advanced Cancer: A Meta-Analysis of Randomized Controlled Trials
    Geiger-Gritsch, Sabine
    Stollenwerk, Bjoern
    Miksad, Rebecca
    Guba, Beate
    Wild, Claudia
    Siebert, Uwe
    [J]. ONCOLOGIST, 2010, 15 (11): : 1179 - 1191
  • [4] Efficacy of pain education in cancer patients: A meta-analysis of randomized controlled trials
    Jho H.J.
    Myung S.-K.
    Chang Y.-J.
    Kim D.-H.
    Ko D.H.
    [J]. Supportive Care in Cancer, 2013, 21 (7) : 1963 - 1971
  • [5] Angiogenesis inhibitors for patients with ovarian cancer: a meta-analysis of 12 randomized controlled trials
    Li, Xuyuan
    Zhu, Sujuan
    Hong, Chaoqun
    Cai, Haoquan
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (03) : 555 - 562
  • [6] Hypertension associated with niraparib in cancer patients: A pharmacovigilance analysis based on the FAERS database and meta-analysis of randomized controlled trials
    Chen, Wei
    Xie, Jiyi
    Gao, Chen
    Zhang, Cong
    Fu, Zhiwen
    Shi, Chen
    [J]. GYNECOLOGIC ONCOLOGY, 2024, 182 : 108 - 114
  • [7] Efficacy and safety of intraperitoneal chemotherapy in patients with advanced gastric cancer: a cumulative meta-analysis of randomized controlled trials
    He, Zheng
    Zhao, Ting-Ting
    Xu, Hui-Mian
    Wang, Zhen-Ning
    Xu, Ying-Ying
    Song, Yong-Xi
    Ni, Zhong-Ran
    Xu, Hao
    Yin, Song-Cheng
    Liu, Xing-Yu
    Miao, Zhi-Feng
    [J]. ONCOTARGET, 2017, 8 (46) : 81125 - 81136
  • [8] Efficacy and Safety of Compound Kushen Injection on Patients with Advanced Colon Cancer: A Meta-Analysis of Randomized Controlled Trials
    Yu, Lixiu
    Zhou, Ying
    Yang, Yu
    Lu, Furong
    Fan, Yeqin
    [J]. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2017, 2017
  • [9] Efficacy and Safety of PARP Inhibitor Therapy in Advanced Ovarian Cancer: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials
    Chen, Juying
    Wu, Xiaozhe
    Wang, Hongzhe
    Lian, Xiaoshan
    Li, Bing
    Zhan, Xiangbo
    [J]. CURRENT COMPUTER-AIDED DRUG DESIGN, 2024, 20 (06) : 736 - 751
  • [10] Efficacy and safety of PARP inhibitors in the treatment of advanced ovarian cancer: An updated systematic review and meta-analysis of randomized controlled trials
    Hao, Jiatao
    Liu, Ying
    Zhang, Taohong
    He, Jinmei
    Zhao, Haoyi
    An, Ruifang
    Xue, Yan
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 157